Trailing-twelve-month (TTM) net income is $1.38 Billion with a year-over-year change of (6.97%). Net income represents the company's bottom line profit after all expenses, taxes, and interest.
Reported quarterly net income; no daily interpolation. Q1 FY2027 (2026-07-31): $438.00M.
Net Income growth vs the same fiscal quarter in the prior fiscal year, last 4 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-09-11T09:21:12.640Z. Historical observations retain their original dates. Historical series through 2026-09-09.
$1.38B
$1.38 Billion
(6.97%)
vs. $1.48B a year ago (TTM)
(6.44%)
3 Year compound annual growth rate
1 Year
(6.97%)
3 Year
(6.44%)
5 Year
N/A
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Net Income | YoY Change | % Change |
|---|---|---|---|
| 2026 | $1.32B | ($185.50M) | (12.28%) |
| 2025 | $1.51B | ($87.90M) | (5.50%) |
| 2024 | $1.60B | ($19.30M) | (1.19%) |
| 2023 | $1.62B | +$366.60M | +29.30% |
TTM Growth
(6.97%)
3-Year CAGR
(6.44%)
5-Year CAGR
N/A
Unrounded diluted TTM EPS / FMP quote price × 100 Quote observation: 2026-09-11T09:21:12.640Z. Historical observations retain their original dates. Historical series through 2026-09-09.
